Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Nature Communications|November 11, 2024
A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulationM Teresa Bertran, Robert Walmsley, Thomas Cummings, et al.Nature Communications|May 4, 2019
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF<sup>V600E</sup> amplification whereas KRAS<sup>G13D</sup> amplification promotes EMT-chemoresistanceMatthew J Sale, Kathryn Balmanno, Jayeta Saxena, et al.Science Signaling|April 14, 2011
PI3Kβ plays a critical role in neutrophil activation by immune complexesSuhasini Kulkarni, Cassian Sitaru, Zoltan Jakus, et al.Plos Medicine|October 12, 2021
Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.Molecular Cell|August 11, 2023
PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostateTamara A M Chessa, Piotr Jung, Arqum Anwar, et al.Plos One|March 24, 2022
Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trialLauren Burke, Elizabeth Littlewood, Samantha Gascoyne, et al.Evidence-Based Mental Health|October 12, 2022
Can we mitigate the psychological impacts of social isolation using behavioural activation? Long-term results of the UK BASIL urgent public health COVID-19 pilot randomised controlled trial and living systematic reviewElizabeth Littlewood, Dean McMillan, Carolyn Chew Graham, et al.The Lancet. Healthy Longevity|February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.Pageof 8